In a new article from the San Diego Business Journal, Natallie Rocha speaks with Yaron Hakak, Jumpcode Genomics CEO, about a collaboration with the Translational Genomics Research Institute (TGen) to help sequence and examine the genomic epidemiology of SARS-CoV-2, the virus that causes COVID-19. The collaboration will give researchers the opportunity to examine the specificity …
Collaboration leverages CRISPRclean™ technology for genomic sequencing to help identify and track COVID-19 variants SAN DIEGO, Calif. — September 14, 2021 — Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today a collaboration with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, to …
Jumpcode Genomics and TGen Partner on Genomic Sequencing of COVID-19 Read More »
In a new article from Genetic Engineering & Biotechnology News (GEN), Gail Dutton speaks with Yaron Hakak, Jumpcode Genomics CEO, on how our CRISPRclean™ technology can cut the clutter from sequencing libraries. Much of the information generated by next-generation sequencing is biologically uninformative, but this information keeps filling NGS libraries anyway, creating background noise and …
CRISPR-Cas9 Technology Cuts Clutter from Sequencing Libraries Read More »
Welcomes Vice President of Research and Development, Vice President of Marketing and Vice President of Sales to fuel innovation and growth SAN DIEGO, Calif. — April 29, 2021 — Jumpcode Genomics, a genome technology platform company focused on enabling genomic analysis, today announced the appointment of three new key hires to its growing team. Jon …
Jumpcode Genomics Expands Team with Appointment of Three Executives Read More »
In a new article from GenomeWeb, Senior Editor Christie Rizk speaks with Nicholas Schork, Ph.D., Deputy Director and Distinguished Professor of Quantitative Medicine at The Translational Genomics Research Institute, about how Jumpcode’s CRISPRclean™ technology is helping researchers build a better COVID-19 test: While COVID-19 held the world in its grip throughout much of 2020, the …
TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test Read More »
Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, Calif. – Jan. 12, 2021 – Jumpcode Genomics – a genome technology company …
Jumpcode Genomics Secures $21M in Series B Funding Read More »
Kelsey Kaustinen details how Jumpcode’s CRISPRclean technology unites NGS and CRISPR/Cas editing in a Q&A with our Chief Scientist, Dr. Stanley Nelson, in the current issue of Drug Discovery News. Read on to hear Dr. Nelson’s perspective on how CRISPRclean can benefit life sciences and biopharma industry research. Jumpcode details how its CRISPRclean tech unites …
Patented CRISPRclean™ Technology is a Foundational Tool that Improves the Performance of Next-Generation Sequencing and Other Molecular Workflows by Increasing Sensitivity, Reducing Costs and Enabling Novel Discovery CARLSBAD, Calif. – Sept. 17, 2020 – Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and …
Looking for more information? Need technical support?
Send Us A Message